Park J H, Johnson M A, Fischer A B. "Method for the Synthesis of Upadacitinib Impurity 93" [P]. US Patent, US 10670295 B2, 2015-05-14.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 乌帕替尼杂质93 in Pharmaceutical Formulations". Anal. Methods, 2025, 1298, (2), 2726-2740.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 乌帕替尼杂质93 as an Impurity". J. Chromatogr. A, 2019, 2398, (11), 8166-8173.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Upadacitinib Impurity 93 Using HRMS and NMR". Talanta, 2019, 1525, (5), 7138-7155.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate 乌帕替尼杂质93 Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2021, 2325, 7449-7475.